Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Dooradoyle

3 clinical trials in Dooradoyle, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dooradoyle at a glance
3
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Dooradoyle

Open in trial search
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Unicancer
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne
Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Dooradoyle

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on chronic lymphocytic leukemia (CLL) treatment approaches, comparing the effectiveness of different therapeutic combinations including ibrutinib monotherapy versus combination treatments with venetoclax and obinutuzumab.

  • Treatment-naive CLL patients
  • Progression-free survival assessment
  • Novel therapy combinations

This research aims to establish optimal treatment protocols for previously untreated CLL patients.

02 Prostate Cancer Research

Groundbreaking studies in metastatic prostate cancer treatment, evaluating the effectiveness of ADT combined with darolutamide in patients with specific clinical characteristics.

  • Castration-naïve metastatic disease
  • Radiographic progression monitoring
  • Targeted therapy approaches

Focused on improving outcomes for vulnerable patients with newly diagnosed metastatic disease.

03 Advanced Prostate Cancer Therapeutics

Investigation of combination therapies for metastatic castration-resistant prostate cancer (mCRPC), examining the potential benefits of combining pembrolizumab with enzalutamide.

  • Overall survival assessment
  • Radiographic progression tracking
  • Immunotherapy combinations

Evaluating innovative treatment strategies to improve outcomes in resistant disease states.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.